Literature DB >> 1326346

Hetrazepine PAF antagonists.

K Ikegami1, C J Meade, H O Heuer, F Birke.   

Abstract

Hetrazepines such as WEB-2086 or WEB-2170 are potent, specific, competitive PAF antagonists binding at the same site as the PAF molecule. Despite their structural similarity to known hypnotic drugs they lack hypnotic actions. They almost certainly bind not only cell-surface but also intracellular PAF receptors, which may explain their activity in disease models in which adherence of neutrophils or other cell types to the vascular endothelium plays a role.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326346

Source DB:  PubMed          Journal:  J Lipid Mediat        ISSN: 0921-8319


  4 in total

1.  Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.

Authors:  H A Lehr; A S Weyrich; R K Saetzler; A Jurek; K E Arfors; G A Zimmerman; S M Prescott; T M McIntyre
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

2.  Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.

Authors:  M Giral; D Balsa; R Ferrando; M Merlos; J Garcia-Rafanell; J Forn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

3.  Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.

Authors:  F Bussolino; M Arese; G Montrucchio; L Barra; L Primo; R Benelli; F Sanavio; M Aglietta; D Ghigo; M R Rola-Pleszczynski
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

4.  Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.

Authors:  Vikrant K Bhosle; José Carlos Rivera; Tianwei Ellen Zhou; Samy Omri; Melanie Sanchez; David Hamel; Tang Zhu; Raphael Rouget; Areej Al Rabea; Xin Hou; Isabelle Lahaie; Alfredo Ribeiro-da-Silva; Sylvain Chemtob
Journal:  Cell Discov       Date:  2016-07-12       Impact factor: 10.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.